Paper · 41363997
Comparison of Esmolol Versus Landiolol on Mortality in Adult Patients With Sepsis: A Systematic Review and Network Meta-Analysis.
Tang Z and 4 others. Crit Care Med, 2026. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of Esmolol Versus Landiolol on Mortality in Adult Patients With Sepsis: A Systematic Review and Network Meta-Analysis. Papers, record 41363997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41363997
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of Esmolol Versus Landiolol on Mortality in Adult Patients With Sepsis: A Systematic Review and Network Meta-Analysis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Urea | Major topic |
| Sepsis | Major topic |
| Morpholines | Major topic |
| Propanolamines | Major topic |
| Adrenergic beta-Antagonists | Major topic |
| Humans | |
| Network Meta-Analysis as Topic | |
| Intensive Care Units | |
| Randomized Controlled Trials as Topic | |
| Adult |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No.2022YFC2504400 | National Key Research and Development Program of China | PubMed | ||
| No. JSSCBO20220135 | High-Level Talent Project of Jiangsu Province | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,356,643 | Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. | Chem Pharm Bull (Tokyo) | 1992 | https://conductscience.org/library/papers/1356643 | PubMed |
| 2 | 16,272,751 | Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers. | Drug Metab Pharmacokinet | 2005 | https://conductscience.org/library/papers/16272751 | PubMed |
| 3 | 39,380,732 | Association of beta blockers and mortality in adults with septic shock: systematic review and meta-analysis of randomized clinical trial. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39380732 | PubMed |
| 4 | 36,898,507 | GRADE guidance 36: updates to GRADE's approach to addressing inconsistency. | J Clin Epidemiol | 2023 | https://conductscience.org/library/papers/36898507 | PubMed |
| 5 | 37,369,385 | A guide and pragmatic considerations for applying GRADE to network meta-analysis. | BMJ | 2023 | https://conductscience.org/library/papers/37369385 | PubMed |
| 6 | 27,229,645 | Cardiac Function and Dysfunction in Sepsis. | Clin Chest Med | 2016 | https://conductscience.org/library/papers/27229645 | PubMed |
| 7 | 28,524,025 | [Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2017 | https://conductscience.org/library/papers/28524025 | PubMed |
| 8 | 26,053,424 | Network meta-analysis, electrical networks and graph theory. | Res Synth Methods | 2012 | https://conductscience.org/library/papers/26053424 | PubMed |
| 9 | 32,778,601 | Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses. | CMAJ | 2020 | https://conductscience.org/library/papers/32778601 | PubMed |
| 10 | 35,066,509 | Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial. | Shock | 2022 | https://conductscience.org/library/papers/35066509 | PubMed |
1 to 10 of 52
See all 52 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,098,893 | Landiolol in perioperative and critical care: evidence, patient selection, and practical titration for targeted heart rate control: a narrative review. | J Anesth Analg Crit Care | 2026 | https://conductscience.org/library/papers/42098893 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41363997
GET https://conductscience.org/api/papers/v1/41363997/references?page=2